Who
Michael Edward Solomon
Director
Company insider
Files Form 4 as: Director, Protara Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 Jan 2020
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,000 at $0.00 | filing |
| 12 Jun 2025filed 13 Jun 2025 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 7 Jun 2024filed 10 Jun 2024 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 7 Jun 2023filed 8 Jun 2023 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 8 Jun 2022filed 9 Jun 2022 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Jun 2021filed 10 Jun 2021 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Jun 2020filed 11 Jun 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 10 Jan 2020filed 11 Jun 2020 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,500 at $0.00 | filing |
| 10 Jan 2020filed 13 Jan 2020 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,500 at $0.00 | filing |
| 9 Jan 2020filed 11 Jun 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,861 | filing |
| 9 Jan 2020filed 11 Jun 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,676 | filing |
| 9 Jan 2020filed 13 Jan 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,537 | filing |
| 9 Jan 2020filed 13 Jan 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,861 | filing |
| 9 Jan 2020filed 13 Jan 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,676 | filing |
| 9 Jan 2020filed 13 Jan 2020 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,491 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.